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Abstract
Background: Early wheezing and asthma are relevant health problems in the tropics. Mite sensitization is an
important risk factor, but the roles of others, inherent in poverty, are unknown. We designed a birth-cohort study
in Cartagena (Colombia) to investigate genetic and environmental risk factors for asthma and atopy, considering as
particular features perennial exposure to mites, parasite infections and poor living conditions.
Methods: Pregnant women representative of the low-income suburbs of the city were randomly screened for
eligibility at delivery; 326 mother-infant pairs were included at baseline and biological samples were collected from
birth to 24 months for immunological testing, molecular genetics and gene expression analysis. Pre and post-natal
information was collected using questionnaires.
Results: 94% of families were from the poorest communes of the city, 40% lacked sewage and 11% tap-water.
Intestinal parasites were found as early as 3 months; by the second year, 37.9% of children have had parasites and
5.22% detectable eggs of Ascaris lumbricoides in stools (Median 3458 epg, IQR 975-9256). The prevalence of
“wheezing ever” was 17.5% at 6 months, 31.1% at 12 months and 38.3% at 24 months; and recurrent wheezing (3
or more episodes) 7.1% at 12 months and 14.2% at 24 months. Maternal rhinitis [aOR 3.03 (95%CI 1.60-5.74), p=
0.001] and male gender [aOR 2.09 (95%CI 1.09 - 4.01), p=0.026], increased risk for wheezing at 6 months. At 24
months, maternal asthma was the main predisposing factor for wheezing [aOR 3.65 (95%CI 1.23-10.8), p=0.01].
Clinical symptoms of milk/egg allergy or other food-induced allergies were scarce (1.8%) and no case of atopic
eczema was observed.
Conclusions: Wheezing is the most frequent phenotype during the first 24 months of life and is strongly
associated with maternal asthma. At 24 months, the natural history of allergic symptoms is different to the “atopic
march” described in some industrialized countries. This cohort is representative of socially deprived urban areas of
underdeveloped tropical countries. The collection of biological samples, data on exposure and defined phenotypes,
will contribute to understand the gene/environment interactions leading to allergy inception and evolution.
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The causes of asthma and other allergic diseases remain
unknown. Genetic and epidemiological studies suggest
that for these multifactorial diseases the expression of
different phenotypes depend on complex interactions
between susceptibility genes and the environment [1].
This is reflected in the wide differences in prevalence
and natural history of allergic diseases around the world
[2]. In many regions of Latin America asthma is a public
health problem affecting children and adolescents in
urban areas; wheezing, asthma and allergic rhinitis are
very frequent in some regions [3], with rates similar or
even higher than in industrialized countries [4,5]. Inter-
estingly, anticipated protective factors, such as low
hygienic conditions, do not confer protection in poor
and overcrowded communities, where a high prevalence
of asthma and early infections concur [6-8]. In addition,
there are disparities among some phenotypes, such as
allergic sensitization and prevalence of atopic eczema,
when compared to those observed in industrialized
countries [9,10]. In urban zones of Colombia, asthma is
the most common chronic disease in children and IgE
sensitization to mites is a hallmark in most patients
[11-13]. The population of Cartagena, Colombia, has
been previously studied to investigate genetic and envir-
onmental risk factors for asthma and allergy, not only
because asthma is common [14] but particularly because
the city is in a tropical region where a warm and humid
environment, facilitate the growth of a diverse mite
fauna and the perennial exposure to high concentrations
of their allergens [15-17]. Moreover, most of the popula-
tion is poor and exposed to parasites, generating an
interesting setting to study the influence of environmen-
tal factors on the susceptibility to allergic diseases (Fig-
ure 1).
There are few Latin American birth-cohort focused on
allergic diseases [18-20] and they have explored several
phenotypes and risk factors using different study
designs. For example, Lopez et al. detected sensitization
to D. pteronyssinus in 30% of wheezing and 11% of
asymptomatic infants at 12 months of age in a prospec-
tive study (n = 102) in Brazil. They also found a weak
association between wheezing and specific IgE to mites
at 12 months. Environmental exposures and socioeco-
nomic status were not evaluated [18]. Rullo et al. stu-
died the role of respiratory infections, exposure to
mouse allergens and breastfeeding on wheezing in 104
children living in a socially deprived community of Bra-
zil. Analysis at 30 months showed strong association of
wheezing with “respiratory infections requiring antibio-
tics”. No association was found with endotoxin exposure
or mite sensitization [19]. Cooper et al. in a study
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Figure 1 Gene-environment interactions and the susceptibility to allergic diseases in tropical underdeveloped regions. A summary of
risk factors that may influence the inception of wheezing and other allergic phenotypes in socially deprived urban areas of the tropics. Some
may at first instance seem to be protective; however the rates of allergy and asthma in urbanized-areas of South America indicate the contrary.
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Page 2 of 15protocol presented the strategies for investigating the
impact of early life exposure to geohelminth infections
on the development of vaccine immunity, allergic sensi-
tization and allergic inflammatory diseases in 2,403 neo-
n a t e sf o l l o w e du pt o8y e a r so fa g e[ 2 0 ] .O u rs t u d y
population is an urban low-income community of
admixed genetic background [21,22], living in the tro-
pics under limited sanitary conditions and exposed to
mites and helminth allergens. We hypothesize that, for
children growing up under these particular genetic and
environmental conditions, the prevalence of some aller-
gic phenotypes, as well as the nature and effects of risk
factors are different to those found in cohorts from
industrialized countries.
The aims of this study were: 1. To create a commu-
nity-based birth cohort study for analyzing the effects of
allergen exposure, early parasite infections and poor liv-
ing conditions on the inception of allergic diseases, spe-
cially asthma; 2. To evaluate the effects of prenatal and
other risk factors on the prevalence of wheezing and
eczema and 3. To prospectively collect biological sam-
ples of children living in poor neighborhoods of a tropi-
cal city for further immunological testing, molecular
genetics and molecular microbiology screenings. Here
we describe the study protocol, baseline characteristics,
demographical observations and risk factors for wheez-
ing up to 24 months, of the “Risk Factors for Asthma
and Allergy in the Tropics” (FRAAT) study.
Methods
Design, location and study population
The Ethic Committee of the “Fundación Santa Fe de
Bogotá”, Bogotá-Colombia, approved this study (CCEI-
282-206). We created a community based birth cohort
for a prospective follow up and collection of epidemiolo-
gical data and biological samples. Cartagena is a tropical
city in the Caribbean North Coast of Colombia (10° 23’
59″ North, 75° 30’ 52″ West) with an average annual
temperature of 28°C and 80% of relative humidity. Most
inhabitants are poor according to governmental indexes
that assess type of housing, overcrowding (three or
more people per bedroom), access to basic services,
income and school attendance. This socioeconomic stra-
tification ranges from 1 to 6 and 90% of the population
is grouped in the lowest strata, 1 to 3 [23]. The majority
of study participants belonged to the poorest communes
and shared environmental conditions. The genetic back-
ground of this population resulted from racial admixture
between Native Americans, Spaniards, and an important
proportion (37.9%) of African ancestry [22].
Eligibility criteria and enrollment procedures
To ensure adequate representation of the city popula-
tion, pregnant women attending two public medical
centers during parturition (Clínica Maternidad Rafael
Calvo and Centro de Atención Permanente La Cande-
laria) were screened for eligibility by physicians of the
research staff between August 2007 and May 2008.
These centers serve the majority of the lowest social
strata in the city. Mothers were interrogated during
admission to the delivery room, examined and followed
during labor. Only those fulfilling the following criteria
were included: healthy women natives from Cartagena
or residents in the city for at least 5 years prior to preg-
nancy, with singleton pregnancy, without obstetric com-
plications and/or chronic diseases. The exclusion criteria
were: high-risk pregnancy, pre-eclampsia, dystocia, auto-
immune diseases, tumors, or current use of oral ster-
oids, although asthma was not an exclusion criterion.
Informed consent for participating in the study and col-
lecting a cord blood sample was obtained from each
mother before delivery. After birth, newborns were
examined and those fulfilling the following criteria were
included: product of low-risk pregnancy, born by vaginal
delivery with a gestational age between 37 and 42 weeks
according to Lubchenco method [24], without labor
complications, weight > 2500 grams and APGAR score
of at least 7 at five minutes after birth. Children born
prematurely, requiring reanimation, pulmonary matura-
tion with steroids, management in intensive care unit
after delivery or having congenital deformities were
excluded. Three hundred and twenty six mothers agreed
to participate with their child and enrolled the study at
baseline. After delivery, all families received an explana-
tion about the investigation and signed a written
informed consent to participate.
Collection of baseline data and follow-up
Questionnaires were based on the written Spanish ver-
sion of the International Study of Asthma and Allergies
in Childhood, ISAAC [25] and others tested in our
population [9,14]. We added questions to cover particu-
lar factors regarding living conditions and poverty indi-
cators. These questions were tested previously for
sensitivity and specificity in a sub-study of 97 random-
selected women attending the aforementioned public
centers, using as gold standard the direct observation of
homes by the investigators during domiciliary visits. For
those variables related with maternal factors (such as
parity, education, socioeconomic stratum) the mean sen-
sitivity was 94% and mean specificity 92%. For living
conditions and exposures the results were variable,
some questions had good sensitivity and specificity (e.g.,
sewage system), while others had higher sensitivity than
specificity (tap water) and vice versa (trash burning). In
cases of disagreements of answers about a particular
variable, the information taken by the investigators dur-
ing domiciliary visits was used for analysis. The baseline
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Page 3 of 15questionnaire addressing prenatal risk factors was admi-
nistered in the hospital within 24 hours post-partum by
a physician of the research staff interviewing the mother,
with input from relatives on the questions about family
history of allergic disease, parental lineage, etc.. The
variables included antecedents of asthma and allergic
diseases in the mother, father and relatives, socioeco-
nomic status (monthly income, occupation, social stra-
tum), smoking during pregnancy or passive exposure to
c i g a r e t t es m o k e ,e x p o s u r et of u m ef r o mt r a s hb u r n i n g ,
type of domestic cooking fuel (electric, natural gas, char-
coal or firewood); location of the house regarding indus-
trial area and proximity to high-traffic/main roads, pet
ownership and duration of pet contact, building materi-
als of houses, type of floor (tile, bare concrete or soil),
access to tap water and sewage system, dietary control
during pregnancy and antibiotic use. The second ques-
tionnaire was administered by a physician of the
research staff during a domiciliary visit; it was designed
to confirm the information about the houses, the socio-
demographic indicators and self-reported exposures.
Due to logistic reasons (mainly difficulties to find home
addresses), this was done within 3 to 6 months after birth.
The follow up was performed through the outpatient ser-
vice at the Institute for Immunological Research, where
mothers regularly attended for child’s controls or during
domiciliary visits. Follow up to 24 months was completed
in 84% of the children (Figure 2). When performed, the
medical evaluations through 3, 6, 12 and 24 months,
included a post-natal questionnaire, physical examination
and collection of biological samples (Figure 3).
Blood samples
A cord blood sample was obtained from the maternal
portion immediately after delivery. To avoid contamina-
tion with maternal blood, the distal portion of the
Living in rural villages
Innacessible adresses in the city 
Dystocia/labour complication/Cesarea
Pre-eclampsia, Mother refused DĂƚĞƌŶĂůĨĂĐƚŽƌƐ;ŶсϰϰϬͿ
Low birth weight (<2500 g)
Reanimation/Aspiration of amniotic fluid
Premature birth (< 37 weeks)
Short umbilical cord/failure of sampling 
ŚŝůĚĨĂĐƚŽƌƐ;ŶсϭϵϴͿ
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Rh isoimmunization (n = 1)
Family  declined (n = 3)
Impossible to recontact  (n = 12)
Family moved out of city (n = 14)
Social conflicts  (n = 1)
ǆĐůƵĚĞĚ;ŶсϵͿ
Child’s death (n = 1)
Loss of contact (n = 3)
Social conflicts ( n = 2)
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ZĞƐƉŽŶƐĞZĂƚĞ;йͿ
Severe malnutrition (n = 1)
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Figure 2 Flow-chart of data collection and response rates during the first 24 months in the FRAAT study. Responses rates (left boxes)
are shown as a percentage, relative to the total number of screened mothers during recruitment and to the baseline sample size before and
during follow up. Exclusion criteria, applied during recruitment, and drop-out causes (right boxes) are also detailed.
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Page 4 of 15umbilical cord was closed, the cord was thoroughly
cleaned with ethanol and the umbilical vein punctured
with disposable syringe. The blood was collected in ster-
ile 15 mL tubes and transported to the laboratory,
where serum was separated and frozen for future serolo-
gical tests. Blood samples from mothers were taken by
venipuncture within 12 hours after delivery using the
appropriate tubes to obtain sera for antibody determina-
tions and buffy coat as a source of maternal DNA. In
children, blood samples were obtained between 6 and
24 months (Figure 3) by venipuncture using disposable
syringe. Sera were stored at -20°C for antibody determi-
nations and the clot as a source of DNA. Among the
serological test are total IgE and specific IgE to: Derma-
tophagoides pteronyssinus, Blomia tropicalis, Ascaris
spp., purified Ascaris allergens ABA-1 and Asc l 3, cock-
roach, egg, cat epithelia, mouse, cow’sm i l ka n dStaphy-
lococcus aureus endotoxin (SEB). Also, other parameters
of potential value as risk factors, such as vitamin D, will
be evaluated. For RNA collection, 3 mL of cord blood
and infant blood were immediately added to PAXgene
Blood tubes (PreAnalytix Cat. 762165). RNA was
extracted using the PAXgene Blood RNA kit (QIAGEN,
Cat. 762134) and kept frozen at -80°C.
Stool samples and parasitological examination
When possible, a meconium sample was collected after
delivery in sterile 1.5 mL tubes and kept at -20°C. Mothers
were provided with sterile containers and instructed to
collect stool samples from their children at different time
points between 3 and 24 months. Parasitological analyses
were done using 0.85% saline solution and Lugol staining.
Ascaris lumbricoides egg counts were done by the Kato
Katz method using a commercial kit (Copro Kit, C&M
Medical, Brazil) and the results expressed as egg per gram
of feces (epg). The presence of eggs from geohelminths or
parasite visualization were considered diagnostics of active
infection. In order to analyze the gut microbiota using
molecular tools, DNA was extracted from meconium and
s t o o ls a m p l e s( Q I A a m pD N As t o o lM i n ik i t ,Q I A G E N ,
Cat. 515004) following the manufacturer instructions and
stored at -80°C.
Timeline
Questionnaire 
& physical 
exam
Serum Dust 
sample
Blood 
RNA Blood DNA Stool 
Meconiun 
&
Stool 
Mother n = 326 n = 326 n = 200
Newborns n = 326 n = 326** n = 71** n = 90
Child 
(3-6 months)
n = 286* n = 78 n = 272‡ n = 245 n = 45
Child
(12 months)
n = 280 n = 205 n = 9 n = 272 n = 178 n = 57
Child 
(24 months)
n = 274 n = 169 n = 82 n = 153 n = 51
Measurements 
& Analyses
Demographics,
exposures & 
clinical 
outcomes
* (x2) validation 
of lifestyle + 
follow-up 
sIgE, IgA 
IgG 
levels
**from 
cord 
blood
Allergens & 
endotoxin 
levels 
‡House 
floors 
(n = 232)
child’s bed
(n = 347)
Gene 
expression
**from 
cord blood
Genotyping
& re-seq
Parasite 
analysis & 
Kato Katz
Molecular 
analysis of 
gut
microflora
Figure 3 Timeline of data and sample collection from 0 to 24 months.
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For measuring allergen and endotoxin levels, house-dust
samples were collected from children homes at 6 months,
using a vacuum cleaner (Cyking V-CA241HT, LG Elec-
tronics, Korea) adapted to 25 μM cellulose filters. Chil-
dren mattress and bedroom floor were aspirated two
minutes over 1 m
2 area as described [26]. Dust samples
were placed in sterile recipients, weighted and extracted
in 2 mL of pyrogen-free water-0.05% Tween 20 per 100
grams of fine dust, mixed during 1 hour at room tem-
perature and centrifuged (3000 g, 4°C, 10 minutes). An
aliquot of supernatant (1/10 of the total volume) was
kept at -20°C for endotoxin quantification. The sub-
stracted volume was replaced with PBS 10 × -0.05%
Tween 20 10 mM PMSF and mixed overnight for protein
extraction. After centrifugation aliquots for allergen
quantification were obtained and kept at -20°C.
Assessment and validation of clinical outcomes
Wheezing was defined as expiratory stridor with shortness
of breath or whistling on children chest. Mothers were
interrogated on the question “Have your child ever had
wheezing or whistling in the chest at any time in the past?”
For each affirmative response additional validation ques-
tions were done to obtain further information about the
episode, medications and medical management. Only cases
with documented medical diagnosis during visits to health
centers and/or wheeze detected during physical examina-
tion by the research staff, were considered as wheezing epi-
sodes. Based on the number of wheezing between 0 and 24
months, children were classified as: Never wheezers (no
wheezing at any time point), occasional wheezers (1-2 epi-
sodes) or recurrent wheezers (3 or more episodes in 12
months). Eczema was diagnosed when all the following cri-
teria were present: (1) evidence of itchy skin/pruritus, (2)
visible flexural dermatitis, (3) typical morphology and dis-
tribution including facial, neck and extensor involvement
and (4) dry skin, based on Williams [27-29] after Hanifin
[30]. We have used these modified criteria considering that
in this community other causes of “itchy skin” are common
(scabies, insect stings, helminth induced rashes etc); for the
same reason the diagnosis always included medical exami-
nation. All children whose mothers referred having itching
for more than 2 weeks were re-examined every 3 months
during 12 months.
The diagnosis of asthma and other allergic diseases
among mothers was done using a questionnaire, [9] and
physical examination by a physician from the research
staff. Atopy was defined as a positive immediate
r e s p o n s et oo n eo rm o r ea l l e r g e n si nt h es k i np r i c k
tests, performed between 6 and 12 months, during chil-
dren follow up. The test was considered positive if the
mean diameter of the wheal at 15 minutes was > 3 mm
than the negative control. Mothers were tested with a
set of aeroallergens, including mites (D. pteronyssinus, B.
tropicalis, Aleuroglyphus ovatus, Chortoglyphus arcuatus,
Lepidoglyphus destructor, Suidasia medanensis), cock-
roach (Periplaneta Americana), pollen/grass (Betula
alba, Phleum pretense, Artemisia), pets (dog and cat),
and molds (Alternaria alternata, Penicillium cryso-
genum, Aspergillus fumigatus), kindly supplied by Leti,
Spain. Histamine phosphate [10 mg/mL] was used as
positive control and glycerol as negative control. Chil-
dren will be skin tested after the second year of age.
Data analysis
Information from interviews was recorded on paper
forms, reviewed for accuracy and completeness, and then
entered into the database. Statistical analyses were done
using SPSS v.13.0 (Chicago, IL, USA). Frequencies and
descriptive statistics were calculated at baseline, 6, 12 and
24 months. Chi-square was used to analyze the differ-
ences between proportions. For contingency tables with
less than 10 cases in any cell, the Fisher’s exact test was
used. To analyze which parental and/or prenatal factors
were related to the development of wheezing, multivari-
ate analyses were performed with children having com-
plete exposures data at 6, 12 and 24 months. Crude odds
ratios (OR) and 95% confidence interval were calculated.
For risk factors having a significance level p ≤ 0.05,
adjusted odds ratios (aORs) and 95% confidence intervals
(CIs) were obtained using binary logistic and multinomial
logistic regression. Covariates were introduced in the
final model if their inclusion changed the estimate of the
crude OR by more than 10%. The outcome (dependent)
variables were wheezing ever and recurrent wheezing at
6, 12 and 24 months. Variables were analyzed as categori-
cal (e.g. maternal asthma, yes/no) or continuous (e.g.
maternal age, number of siblings, birth weight).
Sample size
We aimed to have at least 100 wheezers with prospec-
tive sampling for immunological and molecular screen-
ings up to 24 months. Based on the national prevalence
rates [9,14], we estimated that a minimum sample of
400 children will give us the possibility to recruit that
number of cases. For association studies, power was cal-
culated assuming an independent case-control design
and expressing the alternative hypothesis as Odds Ratio
(ψ). For a given risk factor the calculation is done by
setting type I error probability at a = 0.05, number of
wheezing cases (n), probability of exposure among non-
wheezers (r0), and the ratio of controls/cases (m) [31].
Results
Demographic characteristics of the population
Three hundred and twenty six mother-infants pairs were
included. Fifty-two families were lost during follow-up
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Page 6 of 15(Figure 2). Reasons for exclusion were: moving out of
city to rural villages (n = 23), lost of contact by inacces-
sible addresses or lack of telephones (n = 16), family
declined (n = 7), social conflicts (n = 3), child dead (n =
1), severe malnutrition (n = 1) and Rh isoinmunization
(n = 1). Most families were lost in the interval of 0 to 6
months (n = 40), afterwards 12 families drop-out
between 7 and 24 months. The sociodemographic
characteristics of the excluded families were similar to
those that continued in the study. Antecedents of aller-
gic diseases were similar between excluded and non-
excluded mothers and did not influence the willingness
to participate. Maternal characteristics and pre-natal
exposures to risk factors are summarized in Table 1. All
families had similar environmental and living conditions.
Ninety four percent of participants were clustered in the
Table 1 Demographic characteristics of mothers and prevalence of prenatal exposures
Baseline 24 months (n = 274)
Factor (n = 326) non wheezers
(n = 169)
wheezers
(n = 105)
Maternal age at child birth [n (%)]
14-18 80 (24.5) 39 (23.1) 27 (25.7)
19-24 139 (42.6) 68 (40.2) 50 (47.6)
25-30 67 (20.6) 36 (21.3) 19 (18.1)
31-35 22 (6.7) 15 (8.9) 5 (4.8)
36-42 18 (5.5) 11 (6.5) 4 (3.8)
Maternal age (Mean ± SD) 23.2 ± 5.83 23.6 ± 6.15 22.5 ± 5.37
Maternal education
None 5 (1.5) 2 (1.2) 2 (1.9)
Primary school only 57 (17.4) 28 (16.5) 15 (14.3)
High school incomplete 142 (43.6) 69 (40.8) 48 (45.7)
High school complete 72 (22.1) 42 (24.9) 23 (21.9)
Technical studies 46 (14.1) 26 (15.4) 15 (14.3)
University 4 (1.2) 2 (1.2) 2 (1.9)
Parity Primipara 134 (41.1) 73 (43.2) 41 (39.0)
No. of other children (Mean ± SD) 1.17 ± 1.35 1.14 ± 1.32 1.19 ± 1.31
Socioeconomic stratum
1 (poorest) 257 (78.8) 135 (79.9) 79 (75.2)
2 59 (18.1) 29 (17.2) 22 (21.0)
3 10 (3.1) 5 (3.0) 4 (3.8)
Type of house
Brick 243 (74.5) 127 (75.1) 79 (75.2)
Wood 83 (25.5) 42 (24.9) 26 (24.8)
Type of house floor
Tile 90 (27.6) 49 (29.0) 28 (26.7)
Bare concrete 172 (52.7) 87 (51.5) 58 (55.2)
Soil 64 (19.6) 33 (19.5) 19 (18.1)
Tap water Yes 290 (89) 147 (87.0) 95 (90.5)
Sewage system Yes 191 (58.6) 101 (59.8) 61 (58.1)
Exposure to pests at home*
Cockroaches 255 (78.2) 137 (81.1) 80 (76.2)
Rodents (mice, rats) 275 (84.4) 139 (82.2) 92 (87.6)
Smoking and contaminants during pregnancy
Maternal smoking (ever) 16 (4.9) 9 (5.3) 3 (2.9)
Maternal smoking during pregnancy 8 (2.5) 5 (3.0) 2 (1.9)
Intradomiciliary passive exposure 142 (43.6) 67 (39.6) 48 (45.7)
Type of domestic cooking fuel
Wood/Coal 39 (12) 19 (11.2) 13 (12.4)
Propane 69 (21.2) 36 (21.3) 20 (19.0)
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Cartagena and the rest in two rural villages, La Boquilla
(3.1%, n = 10) and Pasacaballos (2.8%, n = 9). The ethni-
city of the population was homogeneous, 74.8% of
mothers were born in Cartagena, 24.6% in rural villages
of the Northwest Coast of Colombia and 0.2% in the
inner country. Most of the mothers were young (mean
maternal age ± standard deviation, 23.2 ± 5.8 years),
58.9% multiparous, 59.5% house-wives and 62.5 with
low level of education. Regarding prenatal exposures,
97.5% denied having smoked during pregnancy but
43.6% reported intradomiciliary secondary-exposure to a
median of 35 cigarettes per week (IQR 14 - 70) and 1.36
± 0.68 (mean ± standard deviation) smokers per house-
hold. Some families had habitual contact with fume
from cooking with firewood and/or trash burning at
homes or their neighborhoods. Intradomiciliary expo-
sure to pets during pregnancy was reported in 48.2% of
mothers, being dogs the most common, and to poultry
and pigs in 13.5% (Table 1). The prevalence of allergic
diseases in mothers is presented in Table 2. Asthma and
allergic rhinitis were the most common diseases and
dust mite allergens the main sensitizers. Interestingly,
cases of atopic eczema were not observed in mothers.
Living conditions of children and particular
environmental exposures
Children were visited at home by the research staff to
investigate risk factors and to validate the information
collected in baseline questionnaires. Post-natal sociode-
mographic conditions were similar to those described at
baseline. The infant group included 139 females (48.6%)
and 147 males (51.4%); most of them living in brick
houses with floors of bare concrete, in non-paved
streets. Forty per cent lacked sewage system, 20% toil-
ettes and 11% tap water. Usually there were 6 people
per household and most children lived with their par-
ents, grand-parents, siblings and other relatives; 35% of
them overcrowded, sharing bedrooms and mattresses
with parents and older siblings. Furthermore, 35% of
Table 1 Demographic characteristics of mothers and prevalence of prenatal exposures (Continued)
Natural Gas 244 (74.8) 124 (73.3) 82 (78.0)
Electricity 3 (0.9) 2 (1.18) 1 (0.96)
Trash burning at home during pregnancy Yes 65 (19.9) 34 (20.1) 22 (21.0)
Passive exposure to trash fume at neighborhood Yes 172 (52.8) 88 (52.1) 60 (57.1)
Exposure to pets and to other domestic animals
Living with pet during pregnancy 157 (48.2) 82 (48.5) 52 (49.5)
Dog during pregnancy 143 (43.9) 77 (45.6) 48 (45.7)
Cat during pregnancy 41 (12.6) 23 (13.6) 10 (9.5)
Living with dog/cat during the whole pregnancy Yes 107 (32.8) 55 (32.5) 37 (35.2)
Intradomiciliary contact poultry/pigs during pregnancy Yes 44 (13.5) 20 (11.8) 17 (16.2)
Antibiotics during pregnancy
Yes 159 (48.7)** 80 (47.3) 57 (54.2)
None 157 (48.1) 84 (49.7) 46 (43.8)
Missing/no remember 10 (3.06) 5 (2.95) 2 (1.90)
* As identified by the families by sightseeing and employing active methods of eradication
** The most frequent cause was urinary tract infection. The most frequent antibiotics were ampicillin (32%), cephalosporin (11.9%), amoxicillin (10.6%) and
metronidazole (9.4%).
SD: Standard deviation
Table 2 Maternal antecedents of allergic diseases
(n = 326)
Phenotype n (%)
Current asthma 21 (6.44)
†
Duration of asthma (Mean, SD) 14.0 ± 9.01 years
Current rhinitis 84 (25.7)
‡
Eczema 0 (0)
Food allergy 23 (7.1)
Drug allergy 5 (1.5)
Family history of asthma* 53 (16.3)
Allergic sensitization
(n = 265)**
n (%) Any allergy
symptom (%)***
Atopy (at least 1 positive test) 93 (35) (50.5)
Mite sensitized 82 (30.9) (54.8)
D. pteronyssinus 59 (22.3) (59.3)
B. tropicalis 61 (23.0) (54)
Cockroach 12 (4.5) (58)
Cat 7 (2.6) (42)
Dog 7 (2.6) (57)
Molds (Pen, Asp, Alt) 8 (3.0) (100)
Pollens (Art, Phl, Bet, Acacia) 7 (2.6) (57)
†Probability of exposure in non-wheezers (r0 = 0.05)
‡Probability of exposure in non-wheezers (r0=0.26)
*Asthma in parents, grand-parents and/or siblings
** As defined by skin tests
*** Asthma, rhinitis, reported food allergy
SD: Standard deviation
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Page 8 of 15families had no fridge and 54% lacked sink for dish-
washing. Early infections with parasites were detected as
early as 3 months of age. The most common parasites
were of the genera Entamoeba ssp. Among nematodes
Ascaris lumbricoides was the most frequent, affecting
2.71% of children at 12 months and 5.22% at 24 months
(Table 3). By 12 months, the median egg counts of A.
lumbricoides were low (78 epg, IQR 76-1452) but
increased between the first and the second year (3458
epg, IQR 975-9256), suggesting that in this age range A.
lumbricoides infections are of low intensity (> 90% of
subjects with egg counts < 50.000 epg) [32]. In addition,
101 had received anti-parasitic treatment and 95% at
least one cycle of antibiotics (mean age of the first treat-
ment 2 ± 3.4 months), due in part to the high preva-
lence of infectious diseases, e.g. pneumonia, urinary
tract infections, bacillary dysentery.
Prevalence of wheezing and atopic eczema
T h ep r e v a l e n c eo f“wheezing ever” was 17.5% at 6
months, 31.1% at 12 months and 38.3% at 24 months.
Recurrent wheezing (3 or more episodes) was present in
7.1% of children at 12 months and 14.2% at 24 months
(Table 4). As confirmed by questionnaires and medical
records, 94% of children wheezing between 0 and 24
months attended a medical center or emergency room
at least once; 84% received salbutamol, 76% antihistami-
nics and 43% oral steroids. Hospitalizations were docu-
mented in 23% of cases. In addition, half of children
wheezing between 0 and 6 months continued wheezing
until 24 months. At 24 months, 18.8% of children had
experienced at least one episode of skin rash/hives,
11.8% of them treated with antihistamines by a physi-
cian. In 7.4% of cases no potential inducer could be
identified. Drugs were commonly incriminated (6.9%),
including antibiotics (amoxicillin, ampicillin) and anti-
inflammatories (metamizole, ibuprofen). In 1.8% of cases
the symptoms were related to food ingestion. Only two
cases of rash/hives induced by egg ingestion and two
cases by milk were clinically documented by the staff.
According to our diagnostic criteria, no case of eczema
was detected between 0 and 24 months.
Risk factors for wheezing during the first two years
We analyzed the effects of prenatal sociodemographic
characteristics and environmental exposures on the risk
of wheezing at 6, 12 and 24 months and/or recurrent
wheezing during the first 24 months (Table 5). Mater-
nal-allergic traits were the most important predictors of
children’s susceptibility during the first two years of life.
Maternal allergic rhinitis was associated with wheezing
ever at 6 months and this association held up after
adjustment for gender [aOR 3.03 (95%CI 1.60-5.74), p=
0.001]. Male gender was associated with increased sus-
ceptibility of wheezing during the interval 0 to 6
months, and the effect was independent of maternal rhi-
nitis [aOR 2.09 (95%CI 1.09 - 4.01), p=0.026]. There
was association between maternal asthma and increased
risk of wheezing between 7 and 12 months, maintained
after adjustment by maternal age and child gender [aOR
3.87 (95%CI 1.24-12.1), p=0.02]. When pooling all
wheezing cases during 0 to 12 months (n = 87), mater-
nal asthma was associated with wheezing [aOR 3.48
(95%CI, 1.27-9.54), p=0.015], but the effect of gender
Table 4 Frequency of wheezing among children from 0 to 24 months
0-6 months
(n = 286)
7-12 months
(n = 280)
13-24 months
(n = 274)
Cumulative
0-12 months
(n = 280)
Cumulative
0-24 months
(n = 274)
Wheezers (n) 50 59 64 87 105
Non-wheezers (n) 236 221 210 193 169
Prevalence of wheeze (%) 17.5 21.1 23.4 31.1 38.3
Occasional wheezers (1 or 2 episodes) - - - 67 (23.9%) 66 (24.1%)
Recurrent wheezers (3 or more episodes) - - - 20 (7.1%) 39 (14.2%)
Children that only wheeze at time interval (n) 21 17 19 --
Number of children that wheeze for the first time at each time interval 50 37 19 --
Table 3 Prevalence of parasitic infection as determined
by stool examination
0-6 months
(n = 200)
0-12 months
(n = 258)
13-24 months
(n = 153)
Any parasite 17 (8.5%) 62 (21.3%) 58 (37.9%)
Polyparasitism 1 (0.5%) 2 (1.13%) 9 (5.88%)
Protoozoan
Entamoeba ssp. 12 (6%) 34 (13.1%) 31 (20.2%)
Giardia lamblia 1 (0.5%) 12 (4.65%) 18 (11.7%)
Blastocystis hominis 1 (0.5%) 3 (1.16%) 3 (1.96%)
Endolinax nana 0 (0%) 1(0.38) 2 (1.30%)
Balantidium coli 0 (0%) 0 (0%) 1 (0.65%)
Helminths
Ascaris lumbricoides 2 (1%) 7 (2.71%) 8 (5.22%)
Trichuris trichiura 0 (0%) 2 (0.77%) 2 (1.30%)
Ancylostoma duodenalis 2 (1%) 3 (1.16%) 3 (1.96%)
Strongyloides stercolaris 0 (0%) 0 (0%) 1 (0.65%)
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Page 9 of 15Table 5 Unadjusted associations between maternal factors and prenatal exposures on the risk of wheezing
6 months 7 - 12 months 0 - 24 months
Factor/exposure Wheezing ever
(n = 50/236)
Wheezing ever
(n = 59/221)
Wheezing ever*
(n = 105/169)
Recurrent wheezing*
(n = 39/235)
OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value
Maternal asthma 1.19 (0.38-3.74) 0.76 2.73 (1.06-7.03) 0.03† 2.35 (0.91-6.06) 0.069 3.10 (1.10-8.73) 0.025¶
Maternal rhinitis 2.80 (1.50-5.24) 0.001
‡ 1.14 (0.61-2.11) 0.67 1.73 (1.02-2.93) 0.041 1.78 (0.88-3.58) 0.10
Mother education
< 5 0.81 (0.33-1.98) 0.65 0.76 (0.31-1.85) 0.54 0.99 (0.48-2.01) 0.98 0.92 (0.33-2.55) 0.88
> 11 1.22 (0.50-2.99) 0.65 1.31 (0.54-3.19) 0.54 1.00 (0.49-2.05) 0.98 1.07 (0.39-2.97) 0.88
Parity
Primiparous 0.96 (0.52-1.79) 0.91 1.03 (0.57-1.84) 0.91 0.84 (0.51-1.38) 0.49 0.97 (0.48-1.93) 0.93
Type of house
Wood 0.60 (0.27-1.31) 0.20 0.89 (0.45-1.75) 0.74 0.99 (0.56-1.74) 0.98 0.40 (0.15-1.07) 0.069
Type of floor
Soil 0.94 (0.37-2.36) 0.90 0.73 (0.31-1.73) 0.48 1.00 (0.48-2.09) 0.98 0.76 (0.28-2.07) 0.59
Tap water
No 0.64 (0.21-1.93) 0.43 0.35 (0.10-1.20) 0.09 0.70 (0.31-1.55) 0.38 0.59 (0.17-2.04) 0.40
Sewage
No 1.05 (0.56-1.96) 0.86 0.87 (0.48-1.58) 0.66 1.07 (0.65-1.75) 0.78 0.60 (0.29-1.24) 0.16
Socioeconomic strata
1 (poorest) 1.10 (0.51-2.35) 0.80 0.59 (0.31-1.14) 0.12 0.76 (0.42-1.36) 0.36 0.92 (0.41-2.07) 0.84
Prenatal exposure to cigarette smoke
Yes 1.43 (0.77-2.64) 0.24 0.99 (0.55-1.77) 0.98 1.28 (0.78-2.09) 0.32 0.95 (0.48-1.90) 0.89
Exposure to fume wood/coal
Yes 0.42 (0.12-1.43) 0.16 1.23 (0.52-2.88) 0.63 1.11 (0.52-2.36) 0.77 1.46 (0.55-3.81) 0.43
Exposure to fume trash burning:
at home 0.95 (0.44-2.04) 0.90 0.87 (0.42-1.81) 0.71 1.05 (0.57-1.92) 0.86 0.67 (0.26-1.69) 0.40
at neighborhood 1.33 (0.71-2.47) 0.36 1.08 (0.61-1.93) 0.77 1.22 (0.75-2.00) 0.41 1.62 (0.80-3.28) 0.17
Pets during pregnancy
Intradomicilliary (9 mo) 1.01 (0.55-1.87) 0.95 1.23 (0.67-2.23) 0.49 1.12 (0.67-1.88) 0.64 1.12 (0.55-2.28) 0.74
Intradomicilliary (ever) 1.09 (0.58-2.07) 0.77 0.92 (0.52-1.64) 0.79 1.04 (0.64-1.69) 0.87 0.99 (0.50-1.95) 0.98
Dog at home 0.97 (0.52-1.80) 0.93 0.91 (0.51-1.63) 0.77 1.00 (0.61-1.64) 0.98 0.80 (0.40-1.59) 0.53
Cat at home 0.93 (0.36-2.38) 0.89 0.78 (0.30-1.98) 0.60 0.66 (0.30-1.46) 0.31 0.81 (0.26-2.45) 0.71
Poultry/pigs at home 1.39 (0.62-3.15) 0.41 1.64 (0.76-3.55) 0.20 1.43 (0.71-2.89) 0.30 1.49 (0.60-3.68) 0.38
Rodents at home 0.84 (0.38-1.88) 0.68 1.24 (0.54-2.83) 0.60 1.52 (0.75-3.08) 0.23 0.82 (0.33-2.01) 0.67
Cockroaches at home 0.92 (0.44-1.94) 0.84 0.93 (0.46-1.86) 0.83 0.74 (0.41-1.35) 0.33 0.85 (0.38-1.92) 0.70
Gender
Male 1.87 (0.99-3.51) 0.052
§ 1.37 (0.76-2.45) 0.28 1.61 (0.98-2.64) 0.055 1.47 (0.74-2.93) 0.26
*Cumulative prevalence
†If the true odds ratio for disease in exposed subjects relative to unexposed subjects is (Ψ = 2.73), the test rejects the null hypothesis that this odds ration
equals 1 with 0.56 power
Maternal asthma “Yes” (5.4% in non-wheezers vs. 13.6% in wheezers)
¶ If the true odds ratio for disease in exposed subjects relative to unexposed subjects is (Ψ = 3.10), the test rejects the null hypothesis that this odds ration
equals 1 with 0.55 power
Maternal asthma “Yes” (5.5% in non-recurrent vs. 15.4% in recurrent wheezers)
‡If the true odds ratio for disease in exposed subjects relative to unexposed subjects is (Ψ = 2.8), the test rejects the null hypothesis that this odds ration equals
1 with 0.89 power
Maternal rhinitis “Yes” (26.3 in non-wheezers vs. 50% in wheezers); (25.4% in non-wheezers vs. 37.1% in wheezers at 24 months)
§ If the true odds ratio for disease in exposed subjects relative to unexposed subjects is (Ψ = 1.87), the test rejects the null hypothesis that this odds ration
equals 1 with 0.50 power
Male gender “Yes” (48.7% in non-wheezers vs. 64% in wheezers)
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Page 10 of 15was no longer significant [aOR 1.2 (95%CI, 0.95-2.1), p
= 0.07]. Maternal asthma was the only prenatal factor
associated with wheezing at 24 months [aOR 3.65 (95%
CI 1.23-10.8) p=0.01], after adjustment by maternal
age, number of siblings and child birth weight and gen-
der. Moreover, it was associated with recurrent wheez-
ing (Table 5), with significant effects after adjustment
f o rm a t e r n a la g e ,n u m b e ro fs i b l i n g sa n db i r t hw e i g h t
[aOR 4.42 (95%CI 1.46-13.4), p=0.008]. Maternal atopy
in the absence of asthma was not associated with
wheezing at 12 [OR 1.46 (95%CI 0.81-2.63), p=0.2)]
and not significantly associated with wheezing at 24
months [OR 1.67 (95%CI 0.95-2.9), p=0.07]. Number
of sibling alone was not associated with wheezing [OR
1.03 (95%CI 0.85-1.24) p=0.73].
There was no association between natural or propane
gas and wheezing. In addition, no association was found
between wheezing and conditions considered protective,
such as poverty and coexistence with pets and poultries.
Furthermore, we found no association with well known
risk factors, such as cigarette smoking or passive expo-
sure during pregnancy.
Bronchiolitis during the first 6 months was an impor-
tant risk factor for wheezing at 6 months (aOR 18.3
(95%CI 7.6-44.0), p < 0.0001) and 24 months (aOR 20.6
(95%CI 6.08-70.1), p< 0.0001). Also for recurrent wheez-
ing at 24 months (aOR 6.8 (95%CI 3.0-15.5), p <
0.0001), after adjustment for maternal asthma, maternal
age, number of siblings and children gender.
Discussion
Birth cohort studies in different environments and
populations are useful to understand the natural history
of allergic diseases. Nowadays there are a number of
such studies, most of them multicentric, with some
common objectives and including a wide range of parti-
cipants [33-36]. The results, mainly from Europe and
U S ,h a v es h o w nt h ei m p o r t a n c eo fp a r t i c u l a ra n dc o m -
mon risk factors and their differential influences on
allergic diseases, supporting the relevance of doing this
type of investigations worldwide, to evaluate the great
diversity of settings associated, not only with the cli-
mate, geographical location and genetic background, but
also with low socio-economic conditions that generate
particular risk factors and limit the access to health ser-
vices. The prevalence of allergic diseases varies among
regions and in Latin America, figures of asthma and
other allergies in children are very high [37-42]. How-
ever, as mentioned, prospective birth cohorts in the
region are still scarce, although a growing number are
being reported [18-20].
A remarkable finding in our study is the high preva-
lence of wheezing ever and recurrent wheezing, higher
than reported in some European cohorts [43-46], similar
to data from the USA [47,48] and lower than those
found in some Latin American surveys [19,41]. Consid-
ering that 12% of children of this cohort attended a hos-
pital with bronchiolitis, one explanation of our findings
is the effect of viral diseases, as has been shown in other
studies from Latin America [19]. In fact, bronchiolitis
was a high risk factor for wheezing in our cohort, with
odds ratio similar to that found when laboratory diagno-
sis of viral infection was done [49]. Lower respiratory
tract infections by Respiratory Syncytial Virus (RSV) are
common in tropical developing countries causing 27 to
96% of all acute wheezing hospitalizations in children
under 6 month of age [50]. In our children an important
proportion of wheezing during this period might be
caused by viruses and this related to the finding that
only half of children wheezing before 6 months contin-
ued wheezing until 24 months. However, the existence
of a group with recurrent wheezing (14.2%) suggests
that other factors, including atopy, may be influencing
this phenotype [18]. RSV infections can induce a change
of the Th1/Th2 balance, expressed by an increase of the
IL-4/IFN-gamma ratio and a persistent IgE response
over the years [51,52], and human rhinovirus-induced
bronchiolitis carries a markedly risk of persistent wheez-
ing and childhood asthma [53]. Besides, in the tropics,
co-exposure to perennial high concentrations of mite
allergens and helminth infections may induce an early
allergic response with respiratory effects [54]. Also, liv-
ing in socially deprived urban areas of underdeveloped
countries lead to an early exposure to high levels of
endotoxin, in turn associated with increased risk of
wheezing during the first year of life [55,56]. Allergy
diagnosis by in vitro assays and skin prick tests will help
to improve phenotype definition in our cohort and
obtain data about risk factors for atopy associated-
wheezing [57].
In this study, maternal asthma was consistently asso-
ciated with wheezing and recurrent wheezing in the off-
spring, a finding already observed in different
populations and considered an important risk factor for
asthma in children before 5 years [58-61]. The mechan-
isms of this “maternal effect” and why it is more evident
during early childhood are unknown. It has been
reported that maternal asthma, as well as the child
HLA-G genotype contribute to the presence of bron-
chial hyperreactivity [62]; in addition, several factors
may act in combination with maternal cytokines, antibo-
dies and other mediators that act in utero or during the
perinatal period [63,64]. Furthermore, recent works in
animals suggest that epigenetic mechanisms may play a
role [65,66], although the transmission of the maternal
susceptibility via epigenetic changes or parental imprint-
ing remains to be demonstrated. Remarkably, this asso-
c i a t i o nw a sd e t e c t e da t1 2 ,f r o m1 3t o2 4a n d0t o2 4
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Page 11 of 15months, suggesting that the maternal effect is on chil-
dren that start wheezing after 6 months. Moreover, it
was also evident with recurrent wheezing, a more severe
phenotype and always held up after adjustments for cov-
ariates. These results are in agreement with a study in
Brazil, were parental asthma was associated with atopic
and non-atopic wheezing [67] but in contrast with other
where maternal atopy was a risk factor for wheezing in
poor-environments [68] because we found no associa-
tion between maternal sensitization alone and wheezing.
Additionally, and in concordance with other surveys
[69-71], we found that male gender was associated with
wheezing in cases between 0 and 6 months, but the
effect disappeared with increasing age. As it has also
been reported, the prevalence and severity of asthma are
higher in boys than in girls in the first 10 years of life,
but this pattern is reversed after puberty [72]. Although
the reasons of this observation remain unknown, there
are interesting analysis and hypothesis [73,74].
Contrary to expected, our data show no association of
wheezing with active or passive maternal smoking, and
the low prevalence of self-reported maternal smoking
during pregnancy precluded further association analysis.
Therefore, we investigated association between passive
intra-domiciliary exposure and wheezing at 6, 12 and 24
months but the results were the same. The prevalence
of wheezers was always higher in the group of children
with prenatal passive exposure: 6 months (41.1% vs.
50.0%), 12 months (40.4% vs. 47.1%), and 24 months
(40.0% vs. 45.2%) but this was not statistically signifi-
cant. In addition to the type of housing and cultural pat-
terns, another explanation for these results may be a
Type II error because the sample is underpowered to
detect the effects of smoking. Increasing the sample size
and using biological markers of tobacco exposure could
help to obtain a more accurate analysis.
The mechanisms of atopic dermatitis are not clear but
hereditary factors and environmental exposures are sup-
posed to play important roles [75,76]. A main finding of
this study is that in a socially deprived population of the
tropics, the natural history of atopic conditions seems to
be different to expected according to the “atopic
march”, where eczema appears before the first two years
followed by allergic respiratory symptoms [77,78]. In
fact, we found no cases of atopic eczema during the first
two years of age, while wheezing was a frequent pheno-
type. Although we do not know yet if atopy is playing a
role in the origin of wheezing in these children, it is
clear that early respiratory symptoms predominate over
cutaneous, atopy-associated, symptoms. In addition,
asthma and allergic rhinitis were the most common
allergic manifestations in mothers but there was no
eczema among them. In a previous study we found a
low frequency of atopic dermatitis in the general
population of Colombia [9]. In developed countries, the
prevalence of this disease is around 10 to 20% in chil-
dren under 5 years [79,80], but the ISAAC Phase III
study in Latin America reports that, with some excep-
tions, the prevalence is less than 5% [81]. Under these
rates we expected around 15 cases of eczema in our
cohort.
Increasing evidence suggest that the “atopic march”
includes only a subgroup of patients [82-84]. However,
the reasons we found no cases of atopic eczema should
be further analyzed. We hypothesized that the genetic
background, with an important component of African
ancestry and a different distribution of susceptibility
alleles for eczema could be protective. Also, particular
exposures of these children, with early infections as a
hallmark, may confer protection, as has been suggested
[ 5 6 , 8 5 ] .T h ed i a g n o s t i cc r i t e r i aw eu s e d[ 3 0 ]a r ev e r y
important when aiming to study this disease in the tro-
pics because infections and other medical conditions
producing “itchy skin” are very frequent. Although cases
of eczema may appear in our cohort after 2 years, it has
been suggested that a great number begin within the
first 12 months, disappearing around 3 years in a signifi-
cant proportion of children [86]. Therefore, monitoring
symptoms of this disorder, as well as other allergic dis-
eases in this cohort is mandatory.
There are reports of associations between low income
and asthma [87]. We found no relationship of allergy
symptoms with socioeconomic strata, possibly because
the study population is homogeneously poor and differ-
ences between strata are small. Potential risk factors
related to poverty, such as housing conditions, access to
tap water and sewage system, exposure to fume from
firewood and trash burning, intradomiciliary contact
with poultry and pigs and large family size were not
associated with wheezing. For most of them the preva-
lence of exposure among non-affected was high enough
to detect an effect. Since the study population is not
representative of all the social strata of the city the gen-
eralization of these results is limited. Further research is
needed to evaluate the potential interactions that lead to
allergy phenotypes in socially deprived environments.
S i n c eo u rs t u d yw a sb a s e di nap r o s p e c t i v ec o h o r t
design that included physician assessment of a broad
range of factors, we think that accurate information was
obtained. This strategy may reduce the number of parti-
cipants and requires more resources but it is necessary
to increase accuracy avoiding the bias from poorly
defined phenotypes, as may occur when the information
is obtained only from self-administered questionnaires,
especially in populations with low education level. This
is especially important for atopic eczema and wheezing
because they may not be easily evaluated by parents.
Two sources of ascertainment bias should be
Acevedo et al. BMC Pulmonary Medicine 2012, 12:13
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Page 12 of 15mentioned: one from the type of housing and living
conditions that make it difficult to identify some expo-
sures (e.g. pet ownership, smoke exposure) and other
from the detection of phenotypes. The diagnosis of
wheezing was made only when patients were evaluated
by a physician or had documented history of medica-
tions and hospital admissions, as has been recom-
mended [88] and this might bias our attention to the
most severe cases, lowering the sensitivity of the survey.
However, considering that the biologic samples are
intended for serologic and molecular screenings we
chose for well-defined phenotypes to reduce heterogene-
ity. Among the limitations of this study, one is the small
number of children recruited, if compared to multicen-
ter surveys. Although, according to the formerly
reported prevalence of wheezing in this population our
analyses have good power to detect some associations,
increasing the number of participants could provide bet-
ter information. However, many obstacles must be over-
come to organize a prospective cohort in countries with
high degree of poverty. Low education precludes the use
of self-reported questionnaires, limitingt h en u m b e ro f
enrolled families. Another problem affecting the
response rate and the follow-up is the lack of well urba-
nized neighborhoods, which greatly increase the diffi-
culty of the visits.
As in other birth-cohorts, a valuable selection of bio-
logical material has been done in this study [35].
Laboratory tests will help to assess genetic and environ-
mental factors linked to asthma development, providing
novel information about disease mechanisms in the tro-
pics. An open question when studying allergies in this
zone is the influence of A. lumbricoides infection on the
process of IgE sensitization to common allergens, espe-
cially house dust mites [89]. Thus, IgE serology to
Ascaris spp. and allergen extracts will be serially per-
formed to explore primary sensitizers and how the
infection status influences the frequency and strength of
specific IgE response. Another aspect to be evaluated is
the relationship between the immunological profile at
birth and further wheezing in children. Immune-
responsiveness gene expression will be monitored at dif-
ferent time-points. As differences in microbiota compo-
sition may influence immune response [90-92], stool
samples has been collected from birth to 24 months, to
identify gut microbiota composition and explore their
potential relationship with the IgE responses and
allergies.
Conclusions
Here we describe the demographic characteristics of
the FRAAT birth cohort study, representative of
socially deprived urban areas of underdeveloped tropi-
cal countries. At 24 months, the history of allergic
symptoms is different to the “atopic march” described
in some populations of industrialized countries.
Although the rates of wheezing were higher than those
reported in these countries, cases of eczema were not
found. Wheezing is the most frequent phenotype dur-
ing the first 24 months of life and is strongly asso-
ciated with maternal asthma. The availability of cord
blood serum and other biological samples, will allow to
further study risk factors for asthma and atopy during
early childhood, including the effects of particular fac-
tors related to poverty, such as early microbial and
parasite exposure.
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